Jayjaycee18's Posts
Nairaland Forum › Jayjaycee18's Profile › Jayjaycee18's Posts
I do this often. Sometimes, one has to sell a stock(s) to raise funds to buy another potentially more profitable stock(s). Funding ones account to trade at the current Forex rates can be cumbersome and unprofitable at times. I recall during the Soludo & Ndi-Okereke Onyiuke's days (around 2004-2008) when the Stockbrokers like BGL, Cashcraft and Banks like UBA et al used to give out margin loans of N5m - N10m+ depending on ones salary and if the person's salary account was domiciled in the particular Bank. Some folks made a kill in the NSE trading with these risky borrowed funds, while some unfortunate ones like one Cooperative Society of a multinational company who invested over N4billion margin loan without proper DD, lost a fortune when the NSE went south. OakPearl: |
$PEIX price chart today has formed a head and shoulders (H&S), but price got halted at $7.86 after 18.40% gain. If it breaks $7.93 during power hour (last trading hour) with huge volumes, then it could see $8+ at EOD. |
$SRNE: Announced premarket that its 2 neutralizing antibody trial treatments to be used on critically ill people showed huge positive preclinical results against Covid-19 virus. Share price is 18% up already and just broke $12, seeking $14-$15 by end of day (EOD). |
The US FDA partially halted Inovio's ($INO) phase 2/3 Covid-19 vaccine trials this morning, with request for more details before it can proceed. $INO share price already down -33% in premarket trading. Traders may likely sell off $INO to buy into other vaccine competitors like $VXRT, $SRNE and $IBIO. |
Stocks with potential price action this week: $ACOR (got new enhanced $97m contract from the Dept. of Veterans), $JE (good for day trading today before reverse split tomorrow), $PEIX (gaps to fill btw $8 - $10), $BLNK, $NAK and $SRNE. Not a recommendation to buy. As usual, DD is required before investing in any stock(s). Disclosure: I currently own $JE, $PEIX, $NAK and $SRNE. Had done several swing trades in the past on both $ACOR and $BLNK. Looking to re-enter both today. Bonne chance! |
Good to have you here. I would suggest you focus initially on getting more knowledge of stock investment by reading some investment books and read the early parts of this thread. Once you are done equipping yourself about trading the stock market, you can open a stock trading account preferably with "Trading 212" in order to save money anytime you trade. You may start out by practicing trading on a "dummy" account before proceeding to trade on the "live" account. When it comes to stock(s) to invest, you can either pick from your own research using sites like "fool.com", "cnbc.com","finance.yahoo.com" etc. or you will likely get information here, but you have to carry out due diligence (DD) by doing your own analysis before committing your funds to buy any stock(s). You can invest only the money you don't need immediately because stock investment requires patience and profits may not be come when you expect, until the market recognizes the actual worth of the stock(s) you bought. Mercygreatwoman: |
You are absolutely right. For me, some trading day's are "do nothing" or "siddon look" days. No need to fret too much over paper loss(es) caused by a general market downturn, if one did thorough DD, is convinced of the fundamentals of the stock(s) he/she owns and used Techinical analysis (TA) to determine the best entry and potential exit prices. yom2: |
$JE had been fluctuating like a "yo-yo" in the past weeks while the market was anticipating this news (catalyst) of FERC approval. Would be interesting to see how it trades today, since it had over 41million shares traded yesterday. Looks like MM's and Institutional investors are taking position before finalization of the recapitalization on the 28th of September. yom2: |
AstraZeneca PLC ($AZN) dividend of $0.44 per share just got paid. Sold this stock 2weeks ago after some issues arose from its ongoing Covid-19 vaccine trials. |
Just Energy ($JE - $0.29) announced final approval of agreement from the United States Federal Energy Regulatory Commission (FERC) at 3:30pm yesterday, just before the market closing bell. $JE looking like a potential multi-day runner with its share price already surging higher by 40% in aftermarket trading. Not a recommendation to buy. As always, DD is required before investing in any stock(s). N.B: Will sell another 30% of my $JE shares once my target price is reached before $JE's recapitalization and reverse stock split is finalized on the 28th of September 2020. |
Yeah. I understand your point and that's why I gave two examples. One from the US stock exchange ($PEIX) and the other from the NSE (WAPCO). afroxyz: |
When analysing a stock before investing, one doesn't only have to consider past. The current and potential future earnings of a coy must be factored during analysis to grasp a full picture. From your statement, a stock like $PEIX which had negative EPS and only made it's first profit in last 3years in 2Q20 should be trading below $1 and not at over $7 (i.e. more than 600% gain in last 3months from about $0.3 that it traded back then). $PEIX turnaround and enhanced profitability came from its Mgt's decision to focus more in production of industrial grade alcohol to satisfy the demand of sanitizers market, rather than their less profitable core business of ethanol production. While penny stocks are very risky, if one invests in the right one with huge daily traded volumes, after carrying out the required DD, it is possible to make a kill. Besides, some of the current large cap stocks started out as penny stocks and grew over the years to the price their current price. Company's may have negative EPS and low revenue due to either initial huge investments in research & testing or investments in the turnaround of their business and this doesn't mean they will not become profitable in future after few Quarters of low/poor earnings. A particular case is WAPCO in the NSE that has bounced back stronger after restructuring and selling off the SA business. WAPCO has gradually started rewarding the patient investors who decided to accept the existing risks at that time and bought when the coy's profitability and EPS went south. RabbiDoracle: |
$SINT ($1.95 now): Expecting a huge bullish run in the mid/long term. This coy has medical patented technology that incorporates silicon nitrate into consumer face masks that will catch and kill Covid-19 and Influenza A viruses. Not a recommendation to buy. As always, DD is required before buying any stock(s). Disclosure: I started buying this stock yesterday and hoping that this stock would stay under $2 so i can build up volumes before the potential bull run. |
$NAK share price ($0.96 now) going parabolic (39%+ gain) in leaked premarket news of potential regulatory approval of the controversial Pebble mines situated close to Alaskas fishing waters. Pebble mines is regarded as the most lucrative in the world with huge deposits of copper, gold rhenium (used in military aircrafts) etc. DT sees this as a potential election play and wants to limit influence of China in the precious metals market and he already tweeted about it. DCF models by various analysts see long term price target btw $11 and $24. Not a recommendation to buy. As usual, DD is required before buying any stock(s). Disclosure: I accumulated this stock and had to hang on to it in spite of many dips, while all the regulatory reviews where ongoing with potential risk of $NAK not getting the required approval to proceed and share price going south. |
$ABUS ($2.90): I'm comfortably sitting in "a bus" with relatively affordable fare (share price) and high probability that the driver(s) would safely take all passengers (shareholders) to their choosen destinations. In fact, even if one bus driver (i.e. LNP patent for covid-19 vaccine delivery for $PFE/$BNTX, $MRNA etc.) gets sleepy/tired, the next driver (potential Hepatitis B - HBV drug cure) would take over at the next bus stop and the journey continues till one alights at final (target price) bus stop. Not a recommendation. As usual, DD is required before investing in any stock(s). |
$PEIX almost 30% gain today and 63% since alerted in earlier post below on 28th August. Waiting PAYtiently for $AVGR to follow suit. Not a recommendation. As usual, DD is required before investing in any stock. Jayjaycee18: |
It's quite easy to advise based on the benefit of hindsight. I believe that this thread was created for folks to share ideas, as well as to constructively engage and review stock tips to the benefit of all. Hence, it could probably have done all forumites good if you had stated your point back then (i.e like @ovasabi et al) and not only to be 'observing' until when the market has tanked, before you comment on why folks should not make recommendations on buying of single stocks. The stock market is typically cyclic and as i type this, my account is in the red to the tune of almost $200, but i bought stocks that i researched and i am fine to hold or sell when i have reached my target. There is no substitute for seeking and acquiring knowledge through extensive research via stock investing books, resources and all. To me, the expectation is that every one on this thread is the "guru" of their stockbroking account and should always carry out due diligence before buying any stock(s). No need for the subtle blame game and the attempt to fault the approach of some folks that have choosen to either give recommendations on single stocks against recommending investing in indexes. Almost the entire market is bleeding and folks need to take any profits off the table and rotate away from techs and Pharma coys and gravitate towards recovery stocks. In spite of the downturn in the market, some folks are still making money from coys in other sectors that are currently 'green' like $CCL, $PEIX etc. DeLaRue: |
Go to "cnbc.com" and type in the ticker in the search bar and pronto all the info (i.e. current or closed market price, extended hours/premarket prices, volumes traded etc.) you need will be displayed, including price chart (line,candle, mountain etc.). Highlyfavoured3: |
Trading 212 used to accept deposits from some Naira ATM cards, but recent restrictions of USD transactions using Naira cards by most Nigerian Banks has made it difficult to deposit into Trading 212 via this means. Try to get a USD dorm account that comes with a USD ATM card, fund your Dorm Account and link the ATM card details to your Gpay profile. 2Lynx: |
A stock can be traded in several ways. While one can comfortably JIJO on this stock, it's fundamentals are strong enough for one to also hold. Besides, the coy had sold off and exited loss-making countries and with natural gas prices going up and loans reduced after recapitalization takes effect this September, earnings would improve. Kindly note that this coy is still making profits and beat analysts earnings estimate by 200% with its 1Q21 EPS of $0.43. This EPS was more than the value/price of each share. I can't think of any other company in the market that can say that. Despite having an EPS of $0.43, the market values this stock's price below $1, while some almost bankrupt stocks like Kodak and even Hertz had shot up from $0.40 to $6.0. The stock is undervalued at current price and has a low risk/reward (R/R) ratio. Hence, the future profit potential far outweighs the risk. Penboy: |
Thanks bro. Appreciate your timely contributions here. Did my DD on $OSTK after you highlighted it and i bought my usual 'Afolabi' units at $85 and sold half at $121 for over $900+gain within a 2weeks. Didn't look the way of $OSTK until you mentioned it here. Still holding on to $GOCO (Go health) which you also recommended here after there IPO, even though i am currently down -19%. From my analysis, with medicaid and medicare insurance, $GOCO are sitting on a potential goldmine. Will gladly wait and take the risk of watching it dip. No need fretting over paper loss(es). OakPearl: |
Expecting mid to long term huge runs from these 2 penny stocks $AVGR and $PEIX. 1. $AVGR ($0.49 yesterday, but -2.53% pre-market today): Coy submitted 3 medical patents, which are awaiting the US FDA's approval. These patents are unique with addressable annual market of $400 million. Current analyst's price target is $1.50. 2. $PEIX ($3.80 yesterday, but now 14% up pre-market at $4.32): Tried buying this stock thrice when it was trading at $1+ but failed due to it being closed for trading during it's recapitalization. This coy is a huge market leader of ethanol production and declared first quarterly profits in the last 3 years due to sustained huge demand of ethanol for hand sanitizers. With Covid-19 pandemic not likely to go away any time soon, expect upcoming earnings to be a blowout. From my analysis, this stock locks like a "multibagger". As always, DD is required before buying any stock(s). Disclosure: I started buying the aforementioned stocks yesterday and will keep averaging down on dips. Bonne chance! |
Just Energy ($JE) Fiscal 1Q21 Earnings and approval of recapitalization plans Looks like Christmas came early here. Alerted on this stock on July 27, 2020 and planned to hold between 5-10 years but it's up by about $87% (now $0.57 pre-market) after the shareholders, debt/bondholders had approved the recapitalization plans and release of the following 1Q20 earnings: 1. Base EBITDA from continuing operations of $40.5 million. 67% increase over the comparable prior year period 2. $136.3 million Base gross margin. A 3% increase over the comparable prior year period 3. Reaffirms Base EBITDA guidance range of $130 million to $160 million for fiscal year 2021 4. Strong stakeholder approval on August 27, 2020 of the Recapitalization Plan to de-risk the business Disclosure: I accumulated this stock at an average price of $0.33 and will be looking to sell 70% of my holdings leaving the remaining 30% for the forthcoming 1-for-33 reverse stock split, so i can still own some substantial shares going into the coys future. The majority shareholder of this coy is currently rated as the 3rd richest man in Canada and reports had it that he assured that this coy will not be declared bankrupt under his watch. Coy had paid dividend consistently over the last 11years until last year that it ran into troubled waters. Due diligence required as always before buying any stock. Bonne chance! Jayjaycee18: |
Yes. You need to register on Trading 212 with your gmail account, so that Gpay can link your chosen ATM card details, after identifying you through your gmail account. horlajide: |
StanbicIBTC charges nothing extra on my USD Dorm account. I only had to fund the dorm with USD and linked my USD Mastercard ATM card to Trading 212 via Gpay. No extra charges once i deposit from there into Trading 212 stock account. megamart247: |
Trading 212 has both $ADMA and $SONN. KillamanJoe: |
Convalescent Plasma stocks skyrocket pre-market today, after the US Food and Drug Administration (FDA) issued an emergency use authorization for the use of convalescent plasma yesterday to treat Covid-19, noting that the "known and potential benefits of the product outweigh the known and potential risks of the product." Consequently, penny stocks like $ADMA ($2.52 last Friday) is up 72% pre-market, $SONN ($2.63 last Friday) is up 105% pre-market and $TTOO ($1.45 last Friday) is up 30% pre-market now. As always, DD is required before investing in any stock. Bonne chance! |
Stocks under $10 to watch this week include: 1. $BGFV ($6.65): Strong sales growth in 2Q20 and a re-instated dividend with ex-div date of August 31st. 2. $XSPA ($3.09): Planned expansion of its Covid-19 testing facilities to Newark Airport NJ, after commencing at JFK Airport NY. 3. $HL ($6.04): Outperformed its peers, in spite of Covid-19 disruptions; reported highest quarterly silver production since 2016. 4. $HMHC ($2.77): Missed 2Q20 earnings estimate by $0.03, but this education play is expected to outperform the market in the near future. 5. $OPKO ($4.80): Q2 EPS of $0.05 beat estimate of $-0.07. Exciting contracts to test NFL, NBA and MLS sportsmen. 6. $ABUS ($3.47): Missed 2Q20 EPS estimates by $0.01, but holds key patent for the lipid nanoparticle (LNP) technology delivery system for Covid-19 vaccines being tested by these 3 coys, $PFE/BioNTech, CureVac & Morderna ($MRNA). Huge royalty expected if any of these vaccines is approved. As always, DD is required before investing in any stock. Disclosure: I own shares of all the companies listed above and currently down -5% in $BGFV and -18% in $ABUS. Using dollar-cost averaging (DCA) investment strategy to reduce average purchase price in $ABUS by buying the dips, while i wait for these to come through. Bonne Chance! |
